Results 141 to 150 of about 61,417 (351)

Acquired Vitamin K Deficiency as Unusual Cause of Bleeding Tendency in Adults: A Case Report of a Nonhospitalized Student Presenting with Severe Menorrhagia [PDF]

, 2017
Omid Reza Zekavat, Gholamreza Fathpour, Sezaneh Haghpanah, Seyed Javad Dehghani, Maryam Zekavat, Nader Shakibazad   +5 more
openalex   +1 more source

Late onset Vitamin K deficiency bleeding disorder presenting as nodular purpura in a 3-month-old exclusively breastfed infant

, 2021
Shikhar Ganjoo, Sakshee Madan, Richa Richa, Shashi Sharma   +3 more
openalex   +1 more source

Use of recombinant factor VIIa for hip surgery in a patient with factor-VII deficiency: A case report [PDF]

, 2007
patient with factor-VII deficiency: A case ...
Cashen, Amanda F., Clohisy, John C., Eby, Charles S., Gopalan, Priya K.   +3 more
core   +3 more sources

Severe Factor X deficiency and successful pregnancy outcome: A rare case

Journal of Applied Hematology, 2018
Factor X (FX) is a Vitamin K-dependent, serine protease produced by the liver that serves pivotal role as the first enzyme in the so-called common pathway of coagulation cascade in fibrin formation.
Debraj Basu, Prakas Kumar Mandal, Mostafa Kamal   +2 more
doaj   +1 more source

Hypocoagulation induced by broad-spectrum antibiotics in extensive burn patients

Burns & Trauma, 2019
Background Patients with extensive burns usually develop pro-coagulation soon after the injury if there is no sepsis occurred. We describe the case of an extensive burn adult suffering from hypocoagulation not related to sepsis, but secondary to ...
Jian Liu, Yiqing Liu, Shengjun Liu, Qin Zhang, Jiexin Zheng, Yiwen Niu, Xuefeng Wang   +6 more
doaj   +1 more source

Consideration for care for your patient with cerebral palsy [PDF]

, 2018
Cerebral palsy (CP) is a common developmental neurological disorder affecting about 2-3 children out of 1,000. CP is the result of infant brain damage or abnormal development resulting in impaired muscle control, coordination, tone, reflex, posture, and ...
Cannon, Katlin R, Ryan, Brooke, Stowe, Melissa   +2 more
core   +1 more source

Outcomes and risk factors of hemorrhage in patients with resected brain metastases

International Journal of Cancer, EarlyView.
What's New? Brain metastases may present with hemorrhage, yet risk factors and clinical outcomes remain unclear. Based on a cohort of 880 patients with resected brain metastases, this study identified tumor volume and primary tumor histology (melanoma and non‐small cell lung cancer) as key predictors of hemorrhage.
Melisa S. Guelen, Kiarash Ferdowssian, Niklas Jung, Hava N. Celik, Andrea Dell'Orco, Semil Eminovic, Anton Früh, Majd Samman, Güliz Acker, Arend Koch, Helena Radbruch, Michael Scheel, Mike P. Wattjes, Julia Onken, Peter Vajkoczy, Nils Hecht, Jawed Nawabi, David Wasilewski   +17 more
wiley   +1 more source

Late-onset vitamin K deficiency bleeding in an extremely preterm infant fed an exclusively human milk-based diet.

Journal of Thrombosis and Haemostasis, 2023
V. Vasu, Shaveta Mulla, Atisha Pandya, David Card, Martin J Shearer, Paul Clarke   +5 more
semanticscholar   +1 more source

Indications for use of vitamin k and identification of adverse reactions to oral anticoagulant therapy in hospitalized patients : a descriptive study [PDF]

, 2014
Vitamin K is a substance found at low concentrations in the human body, where it plays important roles in coagulation and calcium retention. The objective was to identify indications for use of vitamin K in a sample of hospitalized patients.
Martinbiancho, Jacqueline Kohut, Mezzalira, Paula Bianchin, Santos, Luciana dos   +2 more
core  

No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjects

International Journal of Cancer, EarlyView.
What's New? Venous thromboembolism (VTE) is common in cancer patients, with direct oral anticoagulants, including rivaroxaban, recommended as first‐line therapy. However, oral anticoagulant use is limited due to the growing use of targeted therapy and concerns about drug‐drug interactions.
Esther M. Hollander, Alessandra I. G. Buma, Jenneke Leentjens, Paddy K. C. Janssen, Michel M. van den Heuvel, David M. Burger, Berber Piet, Rob ter Heine   +7 more
wiley   +1 more source